Antiverse
PrivateLast Round
Series A
Mar 4, 2026
Total Funding Raised
$18.93M
Momentum Score
25 /100
Company Overview
Antiverse is an AI-driven biotechnology company specializing in the design and discovery of antibody therapeutics for challenging drug targets, such as G-protein coupled receptors (GPCRs) and ion channels. The company's platform integrates machine learning and advanced cell line engineering to accelerate the antibody discovery process, aiming to move from target identification to a functional antibody in six months. Headquartered in Cardiff, UK, with offices in Boston, MA, Antiverse collaborates with pharmaceutical companies and develops its own internal pipeline of drug candidates.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antiverse Comps
Public and private peers based on sector, stage, and business model.
Antiverse Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 4, 2026 | ||||
| Seed | Oct 15, 2024 | ||||
| Seed | Mar 2, 2023 | ||||
| Seed | Mar 15, 2021 | ||||
| Grant | Jul 1, 2018 |
Key People
Founding team and executive leadership
Antiverse Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Science Ventures | Seed |
| Cambridge Angels | Seed |
| Soulmates Ventures | Series A |
| Accelerate@Babraham | Grant |
| AngelHub | Seed |
| UK Innovation & Science Seed Fund | Seed |
| i&i Biotech Fund I | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Added Tensor, an investment firm, as a customer.
- Apr 1, 2026
Added Innosparkventures as a customer.
Antiverse Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Antiverse's valuation, stock price, and market status.
